63811-02-9 1H-[1,3,4]Thiadiazino[5,6-b]quinoxaline,7-chloro-1-(2,5-dichlorophenyl)-3-phenyl-
662138-97-8 Bicyclo[2.2.1]heptane-2-methanol, (1S,2S,4R)-
662139-27-7 Benzoic acid,4-[[3-oxo-7-(3-phenyl-1-propynyl)-2(3H)-isoquinolinyl]methyl]-,1,1-dimethylethyl ester
662143-66-0 2(5H)-Furanone, 4-chloro-5-hydroxy-3-methyl-5-phenyl-
662143-67-1 2(5H)-Furanone, 4-chloro-5-hydroxy-5-phenyl-3-propyl-
64585-69-9 taurocholicAcidtrisulfate
97660-19-0 Zanthoxylum mantchuricum, ext.
97660-27-0 Benzenediazonium, 4-C7-17-branched alkyl derivs., reaction products with resorcinol
97660-29-2 Benzenediazonium, 4-[(4-sulfophenyl)azo]-, chloride, reaction products with formaldehyde and salicylic acid
877222-49-6 Ethanethioic acid,S-[2-[[6-([1,1'-biphenyl]-3-ylamino)-6-oxohexyl]amino]-2-oxoethyl] ester
115984-46-8 3-Buten-2-one, 4,4'-(1,3-phenylene)bis-, (E,E)-
1201657-27-3 2-chloro-N-methyl-4-Pyrimidinecarboxamide
1201666-82-1 1,4-bis(3-cyanophenyl)-1H-1,2,3-triazole
116204-81-0 6-Heptenoic acid, 3-oxo-7-phenyl-, methyl ester, (6E)-
116208-94-7 Oxaziridine, 2-(methylsulfonyl)-3,3-diphenyl-
115142-60-4 NA3F N-Glycan
Serving Advanced Chemicals to Global Customers
© 2009 - 2025 USCKS | King-Pharm Ver 3.0